Clinical Trial: Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Obesity
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-blind, Phase 2, Dose-finding Trial of Once Weekly Petrelintide Compared With Placebo in Participants With Obesity or Overweight With Weight Related Comorbidities
Brief Summary:
The main purpose of this study is to compare dose levels of petrelintide versus placebo with regards to effect on body weight, safety, and tolerability.
Read more